| Period Ending | 31-Dec-2011 | 31-Dec-2010 | 31-Dec-2009 | 31-Dec-2008 |
|---|
|
Total Revenue
|
527,999,000
|
485,231,000
|
452,103,000
|
411,810,000
| | Cost of Revenue | 87,388,000 | 77,855,000 | 71,452,000 | 67,991,000 | | |
Gross Profit
|
440,611,000
|
407,376,000
|
380,651,000
|
343,819,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 370,844,000 | 331,714,000 | 300,591,000 | 266,173,000 | | | |
Operating Income or Loss
|
157,155,000
|
153,517,000
|
151,512,000
|
145,637,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 157,155,000 | 153,517,000 | 151,512,000 | 145,637,000 |
|
Interest Expense | (565,000) | (902,000) | (1,243,000) | (1,550,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 40,603,000 | 39,047,000 | 38,413,000 | 36,735,000 |
|
Minority Interest | (109,000) | (384,000) | (257,000) | (161,000) |
|
|
|
Net Income From Continuing Ops | 125,979,000 | 120,024,000 | 115,423,000 | 112,788,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
125,870,000
|
119,640,000
|
115,166,000
|
112,627,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|